Lilly Confirms Date and Conference Call for 2023 Financial Guidance Announcement Eli Lilly and Company (NYSE: LLY) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022. Lilly will also conduct a conference call...
Tuesday, November 29, 2022 BiopharmaWatch Research 1 min read
Key Takeaway: INDIANAPOLIS , Nov. 29, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's
Price reaction · baseline $365.77 (2022-11-28 close) · hit after-hours · 3 other LLY headline(s) in the window, move may be shared
day 0 close · peak
-0.5%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+45%
120-day peak, hindsight
Typical move
2%
average across 15 past catalysts
Lead asset
Dulaglutide
Phase 3 · Type 2 Diabetes Mellitus
Full Press Release Details
INDIANAPOLIS , Nov. 29, 2022 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY ) will announce its financial guidance for 2023 on Tuesday, Dec. 13, 2022 . Lilly will also conduct a conference call on that day with the investment community and media to further detail the company's financial guidance.
The conference call will begin at 9 a.m. Eastern time . Investors, media and the general public can access a live webcast of the conference call through a link that will be posted on Lilly's website at https://investor.lilly.com/webcasts-and-presentations . A replay will also be available on the website following the conference call.
Refer to:
Jordan Bishop; [email protected] ; 317-473-5712 (Media)
Joe Fletcher; [email protected] ; 317-296-2884 (Investors)